Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: Comparison with COPD

Respiratory Medicine

Volumn 101, Issue 4, 2007, Pages 833-838

  Nishiyama, Osamu ^a   Taniguchi, Hiroyuki ^a   Kondoh, Yasuhiro ^a   Kimura, Tomoki ^a   Kato, Keisuke ^a   Ogawa, Tomoya ^a   Watanabe, Fumiko ^a   Arizono, Shinichi ^a  

^a TOSEI GENERAL HOSPITAL   (Japan)

Author keywords

Desaturation; Dyspnoea; Idiopathic pulmonary fibrosis; Six min walk test

Indexed keywords

OXYGEN;

ADULT; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DYSPNEA; EXERCISE TEST; FEMALE; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; FUNCTIONAL STATUS; HUMAN; MALE; OXYGEN SATURATION; PREDICTION; PRIORITY JOURNAL; RATING SCALE;

AGED; DYSPNEA; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; OXYGEN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY FIBROSIS; RESIDUAL VOLUME; TOTAL LUNG CAPACITY; VITAL CAPACITY; WALKING;

EID: 33847317904     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.06.030     Document Type: Article

References (26)

1. Gross T.J., and Hunninghake G.W. Idiopathic pulmonary fibrosis. N Engl J Med 345 (2001) 517-525
2. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 161 (2000) 646-664
3. Swigris J.J., Kuschner W.G., Kelsey J.L., and Gould M.K. Idiopathic pulmonary fibrosis: challenges and opportunities for the clinician and investigator. Chest 127 (2005) 275-283
4. King Jr. T.E. Clinical advances in the diagnosis and therapy of the interstitial lung disease. Am J Respir Crit Care Med 172 (2005) 268-279
5. National Institutes of Health. National Heart, Lung, and Blood Institute. Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, updated 2003.
6. Celli B.R., and MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23 (2004) 932-946
7. Nishimura K., Izumi T., Tsukino M., and Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 121 (2002) 1434-1440
8. Celli B.R., Cote C.G., Marin J.M., Casanova C., Montes de Oca M., Mendez R.A., et al. The body-mass index, airflow obstructions, dyspnea, and exercise capacity indexs in chronic obstructive pulmonary disease. N Engl J Med 350 (2004) 1005-1012
9. American Thoracic Society. ATS statement: guidelines for six-minute walk test. Am J Respir Crit Care Med 166 (2002) 111-117
10. King Jr. T.E., Tooze J.A., Schwarz M.I., Brown K.R., and Cherniack R.M. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 164 (2001) 1171-1181
11. Lama V.N., Flaherty K.R., Toews G.B., Colby T.V., Travis W.D., Long Q., et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 168 (2003) 1084-1090
12. Hallstrand T.S., Boitano L.J., Johnson W.C., Spada C.A., Hayes J.G., and Raghu G. The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis. Eur Respir J 25 (2005) 96-103
13. Eaton T., Young P., Milne D., and Wells A.U. Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 171 (2005) 1150-1157
14. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease: definitions, epidemiology, pathophysiology, diagnosis, and staging. Am J Respir Crit Care Med 152 suppl (1995) 78s-83s
15. Nishiyama O., Taniguchi H., Kondoh Y., Kimura T., Ogawa T., Watanabe F., et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor?. Respir Med 99 (2005) 408-414
16. Nishiyama O., Taniguchi H., Kondoh Y., Kimura T., Ogawa T., Watanabe F., et al. Quadriceps weakness is related to exercise capacity in idiopathic pulmonary fibrosis. Chest 127 (2005) 2028-2033
17. Medical Section of the American Lung Association. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 152 (1995) 1107-1136
18. Hanamoto S., Ohsuji T., Tsuyaguchi I., Kawabata S., and Kimura K. Prediction formulas for pulmonary function tests expressed in linear and exponential form for healthy Japanese adults. Nihon Kyobu Shikkan Gakkai Zasshi 30 (1992) 2051-2060
19. Borg G.A. Psychophysical basis of perceived exertion. Med Sci Sports Exerc 14 (1982) 377-381
20. O'Donnel D.E., and Webb K.A. Exertional breathlessness in patients with chronic airflow limitation: the role of lung hyperinflation. Am Rev Respir Dis 148 (1993) 1351-1357
21. Babb T.G., Viggiano R., Hurley B., Staata B., and Rodarte J.R. Effect of mild-to-moderate airflow limitation on exercise capacity. J Appl Physiol 70 (1991) 223-230
22. O'Donnel D.E., Revill S.M., and Webb K.A. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164 (2001) 770-777
23. American Thoracic Society. Medical Section of the American Lung Association. Dyspnea. Mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med 159 (1999) 321-340
24. Mahler D.A., Weinberg D.H., Wells C.K., and Feinstein A.R. The measurement of dyspnea, contents of two new clinical indexes. Chest 85 (1984) 751-758
25. Swigris J.J., Gould M.K., and Wilson S.R. Health-related quality of life among patients with idiopathic pulmonary fibrosis. Chest 127 (2005) 284-294
26. Swigris J.J., Kuschner W.G., Jacobs S.S., Wilson S.R., and Gould M.K. Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax 60 (2005) 588-594